Daniel S Duick
Overview
Explore the profile of Daniel S Duick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1211
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gharib H, Papini E, Garber J, Duick D, Harrell R, Hegedus L, et al.
Endocr Pract
. 2016 May;
22(5):622-39.
PMID: 27167915
Thyroid nodules are detected in up to 50 to 60% of healthy subjects. Most nodules do not cause clinically significant symptoms, and as a result, the main challenge in their...
2.
Sipos J, Blevins T, Shea H, Duick D, Lakhian S, Michael B, et al.
Endocr Pract
. 2016 Jan;
22(6):666-72.
PMID: 26789352
Objective: The primary objective was to assess the operative rate in patients with a benign result from the Afirma gene expression classifier (GEC) during long-term follow-up at nonacademic medical facilities....
3.
Peleg M, Fox J, Patkar V, Glasspool D, Chronakis I, South M, et al.
Endocr Pract
. 2013 Nov;
20(4):352-9.
PMID: 24246343
Objective: Clinical practice guidelines (CPGs) could have a more consistent and meaningful impact on clinician behavior if they were delivered as electronic algorithms that provide patient-specific advice during patient-physician encounters....
4.
Duick D, Klopper J, Diggans J, Friedman L, Kennedy G, Lanman R, et al.
Thyroid
. 2012 Aug;
22(10):996-1001.
PMID: 22873825
Background: Seventy-five percent of thyroid nodules with indeterminate fine-needle aspiration (FNA) cytology are found to be benign postoperatively. A novel genomic test, the Afirma gene expression classifier (AGEC), has been...
5.
Duick D
Endocr Pract
. 2012 Aug;
18(4):611-5.
PMID: 22849877
Objective: To provide information on molecular biomarkers that can help assess cytologically indeterminate thyroid nodules. Methods: Published studies on immunohistologic, somatic mutation, gene expression classifier, microRNA, and thyrotropin receptor messenger...
6.
7.
Gharib H, Papini E, Paschke R, Duick D, Valcavi R, Hegedus L, et al.
Endocr Pract
. 2010 Jun;
16(3):468-75.
PMID: 20551008
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules are systematically developed statements to...
8.
Gharib H, Papini E, Paschke R, Duick D, Valcavi R, Hegedus L, et al.
Endocr Pract
. 2010 May;
16 Suppl 1:1-43.
PMID: 20497938
No abstract available.
9.
Johnson J, Duick D, Chui M, Aldasouqi S
Endocr Pract
. 2009 Oct;
16(1):47-52.
PMID: 19789156
Objective: To determine whether patients with prediabetes can be accurately and easily identified in clinical settings using a predictive clinical and laboratory model. Methods: This retrospective study examined demographic and...
10.
Petak S, Coble Jr Y, Duick D, Gonzalez-Campoy J, Hodgson S, Leffert J, et al.
Endocr Pract
. 2009 Jun;
15(4):289.
PMID: 19502206
No abstract available.